Advertisement

Effective Treatment of Multiple Sclerosis with Cyclophosphamide with Little Side Effects

  • E. Mauch
  • H. H. Kornhuber
  • U. Pfrommer
  • A. Hähnel
  • H. Laufen
  • H. Krapf
Conference paper

Abstract

Gonsette et al. (1977), Hommes et al. (1980), Hauser et al. (1983) and Carter et al. (1986) demonstrated the efficacy of intensive immunosuppression with CY in MS. The side effects, however, were severe, for example alopecia in 100% of the patients. Furthermore, the total CY dose per life should not be higher than about 50 g (Kornhuber et al. 1987).

Keywords

Multiple Sclerosis Progressive Multiple Sclerosis Neurogenic Bladder Daily Life Activity Hemorrhagic Cystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Carter JL, Dawson DM, Haller DA, Fallis RJ, Stazzone L, Hauser SL, Weiner HL (1986) Five-year experience with intensive immunosuppression in progressive multiple sclerosis using high-dose IV cyclophosphamide plus ACTH. Neurology [Suppl. 1]: 284Google Scholar
  2. Gonsette RE, Demonty L, Delmotte P (1977) Intensive immunosuppression with cyclophosphamide in multiple sclerosis. J of Neurol 214: 173–81CrossRefGoogle Scholar
  3. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL (1983) Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 308: 173–80Google Scholar
  4. Hommes OR, Lamers KJB, Reekers P (1980) Effect of Intensive immunosuppression on the course of chronic progressive multiple sclerosis. J Neural 223: 177–90Google Scholar
  5. Kornhuber HH (1986) Symptomatische Therapie der Multiplen Sklerose. Kassenarzt 8: 35–41Google Scholar
  6. Kornhuber HH, Mauch E (1986) Immunsuppressive Cyclophosphamid-Therapie der multiplen Sklerose mit wenig Nebenwirkungen. Dtsch Med Wschr 111: 1778PubMedGoogle Scholar
  7. Kornhuber HH, Riebler R (1984) Mit der Multiplen Sklerose leben. Die häusliche Behandlung der MS. Schattauer, StuttgartGoogle Scholar
  8. Kornhuber HH, Mauch E, Petru E, Schmähl D (1987) Zum Malignitätsrisiko bei Cyclophosphamid-Therapie der multiplen Sklerose. Dtsch Med Wschr 112: 530PubMedGoogle Scholar
  9. McDonald WI, Halliday AM (1977) Diagnosis and classification of multiple sclerosis. Br Med Bull 33: 4–8PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • E. Mauch
    • 1
  • H. H. Kornhuber
    • 1
  • U. Pfrommer
    • 1
  • A. Hähnel
    • 1
  • H. Laufen
    • 1
  • H. Krapf
    • 1
  1. 1.Fachklinik für NeurologieDietenbronn GmbHSchwendi 1Germany

Personalised recommendations